Purinoceptors mediate renal vasodilation by nitric oxide dependent and independent mechanisms

Kidney International

Volumn 54, Issue 2, 1998, Pages 473-481

  Rump, Lars Christian ^a   Oberhauser, Vitus ^a   Von Kügelgen, Ivar ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Adenosine; ATP; Human renal artery; P1 receptor; P2Y receptor; Rabbit renal artery; Vasodilation

Indexed keywords

2 METHYLTHIOADENOSINE TRIPHOSPHATE; 8 (4 SULFOPHENYL)THEOPHYLLINE; ADENOSINE; ADENOSINE 5' O (2 THIODIPHOSPHATE); ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE TRIPHOSPHATE; CIBACRON BLUE F3GA; ENDOTHELIUM DERIVED RELAXING FACTOR; INDOMETACIN; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PURINE P2 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PURINERGIC RECEPTOR STIMULATING AGENT; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; REAGENT; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTERY DIAMETER; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RENAL ARTERY;

EID: 0031852803     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00002.x     Document Type: Article

References (51)

1. CHURCHILL PC, BIDANI AK: Adenosine and renal function, in Adenosine and Adenosine Receptors, edited by WILLIAMS M, Clifton, Humana Press, 1990, pp 335-380
2. OLSSON RA, PEARSON JD: Cardiovascular purinoceptors. Physiol Rev 70:761-845, 1990
3. OSSWALD H, MÜHLBAUER B, SCHENK F: Adenosine mediates tubuloglomerular feedback response: An element of metabolic control of kidney function. Kidney Int 39(Suppl 32):S128-S131, 1991
4. SPIELMAN WS, AREND LJ: Adenosine receptors and signaling in the kidney. Hypertension 17:117-130, 1991
5. INSCHO EW, MITCHELL KD, NAVAR LG: Extracellular ATP in the regulation of renal microvascular function. FASEB J 8:319-328, 1994
6. NAVAR LG, INSCHO EW, MAJID DSA, IMIG JD, HARRISON-BERNARD LM, MITCHELL KD: Paracrine regulation of the renal microcirculation. Physiol Rev 76:425-536, 1996
7. CHURCHILL PC, BIDANI A: Renal effects of selective adenosine receptor agonists in anesthetized rats. Am J Physiol 252:F299-F303, 1987
8. 2Y receptors stimulate renin secretion by rat renal cortical slices. J Pharmacol Exp Ther 266:160-163, 1993a
9. HOLZ FG, STEINMHAUSEN M: Renovascular effects of adenosine receptor agonists. Ren Physiol 10:272-282, 1987
10. WEIHPRECHT H, LORENZ JN, BRIGGS JP, SCHNERMANN J: Vasomotor effects of purinergic agonists in isolated rabbit afferent arterioles. Am J Physiol 263:F1026-F1033, 1992
11. MARTIN PL, POTTS AA: The endothelium of the rat renal artery plays an obligatory role in A2 adenosine receptor-mediated relaxation induced by 5′-N-ethylcarboxamidoadenosine and N6-cyclopentyladenosine. J Pharmacol Exp Ther 270:893-899, 1994
12. INSCHO EW, CARMINES PK, NAVAR LG: Juxtamedullary afferent arteriolar responses to P1 and P2 purinergic stimulation. Hypertension 17:1033-1037, 1991
13. BARNARD EA, BURNSTOCK G, WEBB TE: The G-protein coupled receptors for ATP and other nucleotides: A new receptor family. Trends Pharmacol Sci 15:67-70, 1994
14. SURPRENANT A, BUELL G, NORTH RA: P2X receptors bring new structure to ligand gated ion channels. Trends Neurosci 18:224-229, 1995
15. INSCHO EW, OHISHI K, NAVAR LG: Effects of ATP on pre- and postglomerular juxtamedullary microvasculature. Am J Physiol 263: F886-F893, 1992
16. 2 inhibits noradrenaline release and purinergic pressor responses to renal nerve stimulation at 1 Hz in isolated kidneys of young spontaneously hypertensive rats. J Hypertens 8:897-908, 1990
17. 2 purinergic receptors. J Pharmacol Exp Ther 265:334-338, 1993b
18. ELTZE M, ULLRICH B: Characterization of vascular P2-purinoceptors in the rat isolated perfused kidney. Eur J Pharmacol 306:139-152, 1996
19. VARGAS F, MORENO MRR, OSUNA A: Renal vascular reactivity to ATP in ageing rats. Med Sci Res 24:263-265, 1996
20. 2X-purinoceptor agonist β,γ-methylene-L-ATP in human cutaneous and renal blood vessels. Br J Pharmacol 116:1932-1936, 1995
21. BURNSTOCK G, KENNEDY C: Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmac 16:433-440, 1985
22. RALEVIC V, BURNSTOCK G: Roles of P2-purinoceptors in the cardiovascular system. Circulation 84:1-14, 1991
23. GALLE J, BASSENGE E, BUSSE R: Oxidized low density lipoproteins potentiate vasoconstrictions to various agonists by direct interaction with vascular smooth muscle. Circ Res 66:1287-1293, 1990
24. WAUD DR: Analysis of dose-response relationships, in Advances in General and Cellular Pharmacology, edited by NARAHASHI T, BIANCHI CP, New York, Plenum Press, 1976, pp 145-178
25. WILLIAMS M, BRAUNWALDER A, ERICKSON TJ: Evaluation of the binding of the A-1 selective adenosine radioligand, cyclopentyladenosine (CPA), to rat brain tissue. Naunyn-Schmiedeberg's Arch Pharmacol 332:179-183, 1986
26. 2X-purinoceptor. Br J Pharmacol 90:383-391, 1987
27. WINDSCHEIF U, RALEVIC V, BAUMERT HG, MUTSCHLER E, LAMBRECHT G, BURNSTOCK G: Vasoconstrictor and vasodilator responses to various agonists in the rat perfused mesenteric arterial bed: Selective inhibition by PPADS of contractions mediated via P2X-purinoceptors. Br J Pharmacol 113:1015-1021, 1994
28. SCHWARTZ DD, MALIK KU: Renal periarterial nerve stimulation-induced vasoconstriction at low frequencies is primarily due to release of a purinergic transmitter in the rat. J Pharmacol Exp Ther 250:764-771, 1989
29. 2-receptor agonist carmoxirole (EMD 45609) on noradrenergic and purinergic neurotransmission in rat isolated kidney. Naunyn-Schmiedeberg's Arch Pharmacol 345:300-308, 1992
30. BOHMANN C, RUMP LC, SCHAIBLE U, VON KÜGELGEN I: α-Adrenoceptor modulation of norepinephrine and ATP release in isolated kidneys of spontaneously hypertensive rats. Hypertension 25:1224-1231, 1995
31. BOHMANN C, VON KÜGELGEN I, RUMP LC: P2-Receptor modulation of noradrenergic neurotransmission in rat kidney. Br J Pharmacol (in press)
32. BURNSTOCK G: Co-transmission. Arch Int Pharmacodyn 304:7-33, 1990
33. VON KÜGELGEN I, STARKE K: Noradrenline-ATP co-transmission in the sympathetic nervous system. Trends Pharmacol Sci 12:319-324, 1991
34. ZIMMERMANN H: Signalling via ATP in the nervous system. Trends Neurosci 17:420-426, 1994
35. 3H]-adenine labelled rabbit kidney following sympathetic nerve stimulation:and its inhibition by alpha-adrenoceptor blockage. Br J Pharmacol 64:239-245, 1978
36. PEARSON JD, GORDON JL: Vascular endothelium and smooth muscle cells selectively release adenine nucleotides. Nature 281:384-386, 1979
37. SEDAA KO, BJUR RA, SHINOZUKA K, WESTFALL DP: Nerve and drug-induced release of adenine nucleosides and nucleotides from rabbit aorta. J Pharmacol Exp Ther 252:1060-1067, 1990
38. RUMP LC, VON KÜGELGEN I: A study of ATP as a sympathetic cotransmitter in human saphenous vein. Br J Pharmacol 111:65-72, 1994
39. YANG S, CHEEK DJ, WESTFALL DP, BUXTON IL: Purinergic axis in cardiac blood vessels. Agonist-mediated release of ATP from cardiac endothelial cells. Circ Res 74:401-407, 1994
40. NEEDLEMAN P, MINKES MS, DOUGLAS JR: Stimulation of prostaglandin biosynthesis by adenine nucleotides. Circ Res 34:455-460, 1974
41. 1-purinoceptois mediating contraction of the rat colon muscularis mucosae. Br J Pharmacol 105:400-404, 1992
42. 2X-purinoceptor ligands. Br J Pharmacol 113:1432-1438, 1994
43. MATHIESON JJI, BURNSTOCK G: Purine-mediated relaxation and constriction of isolated rabbit mesenteric artery are not endothelium-dependent. Eur J Pharmacol 118:221-229, 1985
44. SCHMIDT HHHW, NAU H, WITTFOHT W, GERLACH J, PRESCHER KE, KLEIN MM, NIROOMAND F, BOEHME E: Arginine is a physiological precursor of endothelium-derived nitric oxide. Eur J Pharmacol 154:213-216, 1988
45. BOGLE RG, COADE SB, MONCADA S, PEARSON JD, MANN GE: Bradykinin and ATP stimulate L-arginine uptake and nitric oxide release in vascular endothelial cells. Biochem Biophys Res Com 180:926-932, 1991
46. KITAGAWA S, YAMAGUCHI Y, KUNITOMO M, SAMESHIMA E, FUJIWARA M: NG-nitro-L-arginine-resistant endothelium-dependent relaxation induced by acetylcholine in the rabbit renal artery. Life Sci 55:491-498, 1994
47. ILLIANO S, NAGAO T, VANHOUTTE PM: Calmidazolium, a calmodulin inhibitor, inhibits endothelium-dependent relaxations resistant to nitro-L-arginine in the canine coronary artery. Br J Pharmacol 107: 387-392, 1992
48. NAGAO T, ILLIANO S, VANHOUTTE PM: Heterogeneous distribution of endothelium-dependent relaxations resistant to NG-nitro-L-arginine in rats. Am J Physiol 263:H1090-H1094, 1992
49. COWAN CL, PALACINO JJ, NAJIBI S, COHEN RA: Potassium channel-mediated relaxation to acetylcholine in rabbit arteries. J Pharmacol Exp Ther 266:1482-1489, 1993
50. ZYGMUNT PM, GRUNDEMAR L, HOGESTATT ED: Endothelium-dependent relaxation resistant to N omega-nitro-L-arginine in the rat hepatic artery and aorta. Acta Physiol Scand 152:107-114, 1994
51. RADERMACHER J, FÖRSTERMANN U, FRÖLICH JC: Endothelium-derived relaxing factor influences renal vascular resistance. Am J Physiol 259:F9-F17, 1990